Ryan Hansen is an experienced Principal Scientist in the biotechnology industry with a strong background in preclinical assessment of novel therapeutics in oncology. He earned a PhD in Cancer Biology from the University of Chicago, and a BA in Biology from Saint John's University. He has worked in various organizations, including Boundless Bio as Principal Scientist, Sierra Oncology as Principal Scientist, Pharmacology Shared Resource - University to Colorado Cancer Center as Co-Director, Pharmacology Core as Associate Director for Drug Analysis, Colorado State University as Research Scientist II, CU-Health Science as Post-Doc, The University of Chicago as Resident Head, and The University of Chicago as Graduate Student.

Ryan Hansen's expertise lies in preclinical assessment of novel therapeutics in oncology, which he has honed through his work in various organizations. He also holds a PhD in Cancer Biology and a BA in Biology, adding to his professional experience and expertise. Some possible keywords that describe his professional experience, expertise, skills, and interests include Preclinical Assessment, Novel Therapeutics, Oncology, Cancer Biology, Biotechnology, Principal Scientist, Research, and Drug Analysis.